for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Journal of Cardiovascular Surgery
  [SJR: 0.723]   [H-I: 44]   [3 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 0021-9509 - ISSN (Online) 1827-191X
   Published by Minerva Medica Homepage  [1 journal]
  • Carotid patch and cerebrovascular event relation after carotid
           endarterectomy procedure.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: On the basis of our results, avoiding primary closure for CEA is defendable. But choice of patch material needs large trials to conclude. PMID: 24598483 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 22 Oct 2016 21:50:02 +010
       
  • Initial single-site experience with the Ovation abdominal stent-graft
           system in patients with challenging aortoiliac anatomy.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Initial outcomes of this single-center experience suggest that the Ovation abdominal stent-graft system is a promising treatment in AAA patients with challenging aortoiliac anatomy. PMID: 24429798 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:03 +010
       
  • Symptomatic abdominal aortic aneurysm repair: to wait or not to wait.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: In a substantial amount of patients with an alleged symptomatic AAA, delayed surgery with patient optimisation might be justified. However, specific criteria in order to select patients that might benefit from delayed surgery need further investigation. PMID: 23867861 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:03 +010
       
  • High sensitivity C-reactive protein and vascular endothelial growth factor
           as indicators of carotid plaque vulnerability.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: This study suggests that serological determinants are useful in recognizing the structural and biological vulnerability of carotid plaques. PMID: 24647324 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Reintervention following endovascular abdominal aneurysm repair is
           uncommon after five-years: results of greater than a decade follow-up.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Stable long-term aneurysm exclusion was achieved in the majority of patients with most re-interventions occurring early in the follow up period. Whilst life-long surveillance should be continued, these data raise the question of the appropriate duration of CT surveillance and suggest that EVAR should be considered for patients with longer life expectancy and favourable anatomy who traditionally would have undergone open repair. PMID: 24647319 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Total aortic endovascular repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: This article gives an overview of available options and the results of endovascular solutions for the entire aorta from the ascending aorta to the iliac artery. PMID: 27654102 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • New tools in endovascular surgery.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Setacci C, Galzerano G, Setacci F, Mele M, Guerrini S, De Donato G PMID: 27654101 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Drug-eluting balloons in below the knee treatment.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : VAN DEN Berg JC The endovascular treatment of atherosclerotic disease of the infra-inguinal arteries has changed significantly since the introduction of drug-eluting balloon technology. The role of angioplasty using drug-eluting balloons for lesions of the superficial femoral and popliteal artery is now well established. The positive results of the use of drug-eluting balloons in the above knee segment could not be achieved in the below-the-knee segment. This paper will give an overview of the current status of drug-eluting balloon angioplasty for below-the-knee lesions, and will present a review of 2 single center registry, 5 randomized trials and a meta-analysis. PMID: 27654100 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Acute stroke endovascular treatment: tips and tricks.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Rangel-Castilla L, Rajah GB, Shakir HJ, Davies JM, Snyder KV, Siddiqui AH, Levy EI, Hopkins LN Acute ischemic stroke is a leading cause of death and disability in the United States, responsible for 1 of every 20 deaths. The efficacy of intravenous tissue plasminogen activator (tPA) alone for recanalization of large-vessel occlusion (LVO) is low. Several randomized trials have now established endovascular treatment of LVO as a standard of care. Endovascular techniques continue to evolve at a rapid pace. This review seeks to report recent advances in endovascular technology, discuss the correlation between speed of reperfusion and patient outcomes, and present mobile stroke care, shortcoming of the recent technology (such as clot fragmentation), and potential soluti...
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • New materials in embolizations.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Maleux G, Cornelissen S, Bonne L Percutaneous, catheter-directed embolotherapy is an established interventional technique for the management of many vascular disorders. For more than three decades, typical embolization devices included macro and microcoils, polyvinyl alcohol microparticles, glue and certain liquids such as absolute alcohol. In the past decade, however, several new embolic devices and refinements of existing embolic devices have arrived on the market and a number of clinical studies have demonstrated their added value. In this review article, these new embolic devices and their typical indications will be discussed, as well as the results of studies involving the embolic devices. PMID: 27647339 [PubMed - in process] (Source: The Journal of Card...
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • New devices to cross chronic total occlusion in critical limb ischemia.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Spanos K, Kouvelos G, Karathanos C, Xhepa S, Athanasios G, Matsagkas M Chronic total occlusions (CTOs) represent a technically demanding subset of lesions, which in most cases require special endovascular methods, advanced operator skills, and utilization of sophisticated assisting devices for successful treatment. CTO crossing devices offer an additional option to interventionists in the treatment of challenging lower extremity peripheral arterial occlusions. These devices may improve crossing rates, allowing delivery of therapeutic devices to the target lesion. Initial technical results seem quite promising, although adequate data on patient and device selection are lacking. Until long-term clinical data verify the durability of those techniques, these devices m...
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Drug-eluting stents in superficial femoral artery treatment: could they be
           the standard of care?
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Bosiers M, Deloose K, Callaert J, Peeters P, Bosiers M Endovascular techniques have improved markedly over the past several decades. Plain old balloon angioplasty can only reach patencies around 40% after 1 year. Scaffolding stents have resulted in improved short-term results but encountered limitations for longer-term durability. With the introduction of drug-eluting technologies the process of intimal hyperplasia might be slowed, resulting in improved long-term patency results. At first, limus-eluting technologies were not able to transfer the enthusiasm from the coronaries to the infrainguinal vascular bed. However, the newer generation paclitaxel-eluting technologies perform significantly better in femoropopliteal arteries than their non-eluting or non-coated ...
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Elliptical transection for eversion endarterectomy enables efficient
           external carotid artery desobliteration.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Elliptical transsection for EEA enables outstanding ECA revascularization with good patency at one year. Type of anesthesia does not affect the quality of the eversion technique. PMID: 24699512 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Treatment strategies for carotid artery aneurysms.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: The etiology, location, and morphology of an ECCA are determining selection of appropriate therapy. Large or tortuous aneurysms, as well as aneurysms involving common carotid or proximal internal carotid artery, are also absolutely indicated to open surgical therapy. Aneurysms which involve the distal internal carotid artery and false anastomotic aneurysms are best managed with endovascular techniques. The ligature is indicated for the treatment of external carotid aneurysms, mycotic aneurysms with local infection and in ruptured ECCA with uncontrolled bleeding. PMID: 24866774 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Pushing forward the limits of EVAR: new therapeutic solutions for
           extremely challenging AAAs using the Ovation ┬« stent-graft.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Our limited and preliminary experience seems to show that Ovation® stent-graft may widen the range of AAAs suitable for standard EVAR. Early results, even in patients with challenging anatomies, are encouraging but a longer follow-up is mandatory. PMID: 25658977 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Carotid artery stenting renaissance: is it safe and effective using new
           materials?
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : De Donato G, Mazzitelli G, Ruzzi U, Mele M, Tadiello M, Giannace G, Setacci F, Galzerano G, Setacci C Data from randomized controlled trials (RCTs) demonstrated significant differences between carotid artery stenting (CAS) and carotid endarterectomy (CEA) in terms of early neurological outcomes (from 0 to 30 days), although mid- and long-term neurological results are indistinguishable. CAS in symptomatic standard risk patients is coupled with a higher risk of any stroke, and death or any stroke at 30 days, while the rates of disabling or major stroke do not vary remarkably between treatments. Since the micro-embolization through the stent struts is the primary suspected cause of suspected early postoperative neurological complications (i.e., non-disabling stroke),...
      PubDate: Tue, 18 Oct 2016 14:45:02 +010
       
  • Paclitaxel-coated versus plain old balloon angioplasty for the treatment
           of infra-inguinal arterial disease in diabetic patients: the Belgian
           diabetic IN.PACT trial.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: The treatment of diabetic PAD of the infra-inguinal arteries with the DCB provides a bettter primary patency rate compared with the plain old balloon angioplasty. The use of DCB did not increase the number of major adverse clinical events when compared with those seen with the use of the uncoated balloons. PMID: 27727202 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Mon, 10 Oct 2016 22:00:00 +010
       
  • Promising role of drug-coated balloons in the tibial vessels'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Langhoff R, Behne A, Buschmann E In order to assess the role of drug-coated balloons (DCB) in below-the-knee (BTK) artery interventions, we analyzed randomized trials which compare coated to non-coated balloons and additionally a direct comparison of drug-eluting stents (DES) with DCB. As angioplasty with non-coated balloons is per guideline-recommendation still standard of care for below-the-knee artery endovascular treatment, we focused on the direct comparison of efficacy and clinical outcome data of both treatment modalities. Data from peer reviewed and published trials were consulted. For each single study, primary and secondary endpoints were reported and compared. Three single-center, non-core lab adjudicated trials showed encouraging data which suggests th...
      PubDate: Sat, 30 Jul 2016 07:38:02 +010
       
  • The use of EndoAnchors to rescue complicated TEVAR procedures.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: EndoAnchors can be safely utilized in TEVAR with high rates of technical success. These results demonstrate the potential to enhance thoracic endograft efficacy and durability with the use of therapeutic and prophylactic EndoAnchors. Long-term data is needed to further define the use of this technology in the thoracic aorta. PMID: 27465392 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 30 Jul 2016 07:38:02 +010
       
  • Towards an entirely endovascular aortic world: an update of techniques and
           outcomes for endovascular and open treatment of type I, II, and III
           endoleaks.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Mangialardi N, Orrico M, Ronchey S, Praquin B, Alberti V, Setacci C Endovascular aneurysm repair (EVAR) is largely the most adopted strategy for aneurysmal disease of the aorta. Nevertheless, the high incidence of reintervention makes it difficult to identify EVAR as a definitive solution; in particular, the most frequent indication of reintervention is endoleak, which is defined as persistent flow into the aneurysmal sac from different sources. Several treatment strategies are described. A contemporary literature search was performed with the intent of describing techniques and outcomes of endovascular and open strategies to type I, II, and III endoleak. Described techniques and outcomes were organized by indication (type I, II, and III endoleak) and by type of a...
      PubDate: Sat, 30 Jul 2016 07:38:02 +010
       
  • Recent developments in the management of adult coarctation.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Nienaber CA PMID: 27366882 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sun, 03 Jul 2016 20:31:02 +010
       
  • Concomitant aortic arch reconstruction using deep hypothermic circulatory
           arrest during heart transplantation.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Hobbs R, Gottret JP, Menon R, Komlo C, Pochettino A, Acker M, Vallabhajosyula P PMID: 27366883 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sun, 03 Jul 2016 20:31:02 +010
       
  • Thrombin injection and compression with removable guidewire in the
           treatment of postcatheterization femoral pseudoaneurysm.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Preliminary data suggest that US-guided percutaneous thrombin injection is a safe and effective method to treat iatrogenic pseudoaneurysms. Simple iatrogenic femoral pseudoaneurysms benefit a single injection of up to 500 units of topical thrombin. We recommend more caution in complex pseudoaneurysms treatment; it is preferable to perform thrombin injection first into the lobe which is not directly joined to the femoral artery. A longer bed rest and closer observation are mandatory during the subsequent 24 hours. If the lobe communicating with the femoral artery is still patent, it can be retreated. Alternatively, we propose a new strategy approach through compression assisted removable "guidewire". PMID: 27366881 [PubMed - in process] (Source: The Journal of Cardiovascula...
      PubDate: Sun, 03 Jul 2016 20:31:02 +010
       
  • Conventional carotid endarterectomy versus stenting: comparison of
           restenosis rates in arteries with identical predisposing factors.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: In this selected group of patients, CEA and CAS were associated with a similar incidence of restenosis. Only 25% of the patients who developed restenosis did so after both procedures. These preliminary findings indicate that individual predisposition does not play a crucial role in the pathogenesis of restenosis. To confirm this conclusion, an analysis of a much larger, multicenter cohort is essential. PMID: 27366880 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sun, 03 Jul 2016 20:31:02 +010
       
  • Efficacy and safety of cutting balloons for the treatment of obstructive
           lesions in the internal jugular veins.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Cutting balloons can be safely used for the management of stenosed internal jugular veins. These devices can replace stents in majority of cases, especially if standard balloon angioplasty is insufficient to restore proper outflow. However, the use of cutting balloons in this particular venous territory is limited by the fact that currently only small diameter devices are available. PMID: 27351869 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Mon, 27 Jun 2016 22:00:00 +010
       
  • Promising role of drug-coated balloons in the tibial vessels'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Langhoff R, Behne A, Buschmann EE To judge on the role of drug-coated balloons (DCB) in below-the-knee (BTK) artery interventions, we analyzed randomized trials which compare coated to non-coated balloons and additionally a direct comparison of drug-eluting stents (DES) with DCB. As angioplasty with non-coated balloons is per guideline-recommendation still standard of care for below- the-knee artery endovascular treatment, we focused on the direct comparison of efficacy and clinical outcome data of both treatment modalities. Data from peer reviewed and published trials were consulted. For each single study, primary and secondary endpoints were reported and compared. Three single-center, non-core lab adjudicated trials showed encouraging data which suggests that DC...
      PubDate: Tue, 21 Jun 2016 22:00:00 +010
       
  • Branched and fenestrated options to treat aortic arch aneurysms.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: As with branched and fenestrated technology for thoracoabdominal aneurysm repair, the use of total endovascular repair for arch pathology will require an evolution in endovascular practice and device design. However, at present, the early use of the latest generation device offers a novel approach to patients who previously had no surgical options. PMID: 27332680 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 21 Jun 2016 22:00:00 +010
       
  • Drug eluting stents remain the golden standard for below-the-knee
           occlusive disease.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: The safety of DES used in BTK occlusive has been clearly proven over the different studies performed in the last years. Good primary patency has been reported for balloon expandable DES but available studies focused on short/focal lesions. Current results support the use of DES in BTK region when a stent is necessary (bail-out) or the total lesion length is short. There is a clear benefit for primary patency, potential clinical benefits and, under these conditions, DES treatment seems to be cost-effective. Further investigation and technology improvement is required to apply these good results to longer and more diffuse lesions. PMID: 27332679 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 21 Jun 2016 22:00:00 +010
       
  • Towards an entirely endovascular aortic world: an update of techniques and
           outcomes for endovascular and open treatment of type I, II, and III
           endoleaks.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Several endovascular means are described in the literature for the treatment of endoleak. PMID: 27332678 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 21 Jun 2016 22:00:00 +010
       
  • A prospective randomized trial comparing endarterectomy to stenting in
           severe asymptomatic carotid stenosis.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: CAS is a maturing procedure and has improved significantly over the past several years. Future developments of stents and protection devices will achieve better perioperative results. This along with our excellent long term results will promote the use of stenting for suitable patients. PMID: 27332677 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 21 Jun 2016 22:00:00 +010
       
  • Women and men derive comparable benefits with an ultra low-profile
           endograft: 1-year results of the European OVATION registry.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Women and men derive similarly favorable benefits with the Ovation stent graft through 1 year follow-up. Longer-term follow-up will be required to determine the durability of these outcomes. PMID: 27327216 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Mon, 20 Jun 2016 22:00:00 +010
       
  • Single center experience with extracranial carotid aneurysm open repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: ECAA open repair represents a safe surgical option, with lower prevalence of complications and no need for reintervention in high volume centers. PMID: 27286522 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 09 Jun 2016 22:00:00 +010
       
  • A new method for precise determination of endograft position and
           apposition in the aortic neck after endovascular aortic aneurysm repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: The new measurement method detected subtle changes in endograft position and apposition during CT follow-up, not recognized initially. It can potentially determine endograft movements and decrease of apposition surface before they lead to complications like type IA endoleaks or uncorrectable migration. A larger follow-up study comparing complicated and non-complicated EVAR patients is needed to corroborate these results. PMID: 27286523 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 09 Jun 2016 22:00:00 +010
       
  • Primary stenting for TASC C and D femoropopliteal lesions: one-year
           results from a multicentric trial on 203 patients.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: This is the largest series of TASC C and D femoro-popliteal lesions primary stenting to our knowledge. The results are encouraging with acceptable primary patency and clinical improvement at 12 months. Results from mid- to long-term follow-up are awaited. PMID: 27272981 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Mon, 06 Jun 2016 22:00:00 +010
       
  • Double-tract vein graft of the lower limb and its efficacy as a conduit
           for tibial bypass.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Komai H, Shindo S, Shigematsu H, Ogino H PMID: 27094428 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • The inflatable-rings fixation mechanism of the Trivascular Ovation┬« Stent
           Graft System: every revolution comes at a price!
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Georgakarakos E, Trellopoulos G, Kontopodis N, Tsetis D, Ioannoub CV PMID: 27094427 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • Initial experience with the inspire MD C-Guard stent in the treatment of
           carotid artery disease.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: We report our experience about the use of this novel stent in the endovascular treatment of carotid artery stenosis, with some technical considerations. Data about patients in whom the Inspire MD C-Guard was used for the treatment of carotid artery diseases were retrospectively collected and analyzed. The procedure was completed in all patients without any intraoperative complications. Postoperative course was uneventful in all cases and no complications have been recorded till now. In our limited experience, the Inspire MD C-Guard has proven to be a safe stent for the treatment of carotid artery diseases. However large studies are needed to better explain strengths and weaknesses of this device. PMID: 27094426 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • TAArget versus EndoFit thoracic stent-grafts in thoracic endovascular
           aortic repair: a retrospective comparison of early and mid-term results in
           a single center.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Better clinical outcomes are highly dependent on accumulated learning curve and improved newer-generation devices and delivery systems. The second generation device TAArget's new featuring uniform external fixation and TTTM Tortuous tracker delivery system allow better external fixation and precise deployment. PMID: 27094425 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • The use of cilostazol in patients with peripheral arterial disease:
           results of a national physician survey.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Among physicians who habitually prescribe cilostazol adherence to the recommended drug dosage and length of treatment is high. The prescription of cilostazol is particularly appreciated in patients with symptomatic intermittent claudication, even before any non-invasive diagnosis of PAD, and before any invasive therapy. Finally a relevant number of physicians regularly prescribe cilostazol also after revascularization, advocating the anti-restenotic properties of the drug. PMID: 27094424 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • Balloon expandable transcatheter heart valves for native mitral valve
           disease with severe mitral annular calcification.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Guerrero M, Urena M, Pursnani A, Wang DD, Vahanian A, O'Neill W, Feldman T, Himbert D Patients with mitral annular calcification (MAC) have high surgical risk for mitral valve replacement due to associated comorbidities and technical challenges related to calcium burden, precluding surgery in many patients. Transcatheter mitral valve replacement (TMVR) with the compassionate use of balloon expandable aortic transcatheter heart valves has been used in this clinical scenario. The purpose of this review was to summarize the early experience including successes and failures reported. TMVR might evolve into an acceptable alternative for selected patients with severe MAC who are not candidates for conventional mitral valve surgery. However, this field is at a very early...
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • Bare metal stent in the peripheral endovascular world… is this
           history' The iliac field.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Deloose K PMID: 27094422 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • Aortic rupture after thoracic endovascular repair in a patient with
           familial thoracic aortic aneurysm and dissections type 6 (FTAAD6).
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Parisi R, Goffi L, Ritelli M, Marinucci L, Secco GG, Uguccioni L, Cocco G, Colombi M, Fattori R PMID: 27094429 [PubMed - in process] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 21 Apr 2016 12:31:02 +010
       
  • Comparison of peri-procedural and mid-term stroke rates and outcomes
           between surgical aortic valve replacement and transcatheter aortic valve
           replacement patients: a single center real world experience.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Even with significant differences in patients' baseline characteristics; in-hospital and mid-term stroke rates are not significantly higher following TAVR than SAVR. Although peri-procedural stroke is not uncommon in TAVR, mid-term stroke rate is low. PMID: 27078127 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 13 Apr 2016 22:00:00 +010
       
  • Mitral valve repair versus replacement - is it a different story for
           percutaneous compared to surgical valve therapy'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Inderbitzin DT, Taramasso M, Nietlispach F, Maisano F The complementary role of mitral valve repair versus replacement is based on evidence of long-term results in open surgery. Transcatheter mitral valve repair and replacement are both under rapid development but subject to clinical feasibility and first in-human short- and midterm outcome studies. The present article aims to review mitral valve repair and replacement by both techniques and to elucidate similar and potentially different aspects among the open and interventional approach. PMID: 27035893 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 31 Mar 2016 22:00:00 +010
       
  • Bare metal stenting of the iliac arteries.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Kim T, Schneider P A significant subset of patients with peripheral artery disease (PAD) has iliac artery involvement that requires treatment. The development of bare metal stents has improved the short- and long-term outcomes of endovascular repair and has become first line therapy. Open surgical bypass has been reserved for extremely complex anatomic morphologies or endovascular failures. It is unclear whether primary stenting is superior to angioplasty with provisional stenting but if angioplasty is used alone, it is likely only appropriate for the most focal lesions. In addition, stent placement at the time of iliac intervention has become so safe that there is no significant added risk when primary stenting is performed. Self-expanding and balloon-expandable ...
      PubDate: Thu, 31 Mar 2016 22:00:00 +010
       
  • The use of cilostazol in patients with peripheral arterial disease:
           results of a national physician survey.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Among physicians who habitually prescribe cilostazol adherence to the recommended drug dosage and length of treatment is high. The prescription of cilostazol is particularly appreciated in patients with symptomatic intermittent claudication, even before any non-invasive diagnosis of PAD, and before any invasive therapy. Finally a relevant number of physicians regularly prescribe cilostazol also after revascularization, advocating the anti-restenotic properties of the drug. PMID: 27035891 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 31 Mar 2016 22:00:00 +010
       
  • Development of parallel graft for arch lesions.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: The results of parallel graft in the aortic arch are promising, but of major concern is still the high rate of Type I endoleaks as well as the neurological complication rate, most probably due to catheter manipulation in patients with severe atherosclerotic arch lesions. PMID: 27029672 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 30 Mar 2016 22:00:00 +010
       
  • Covered stents in iliac artery occlusive: what is the evidence'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Mwipatayi BP, Suthers E, Thomas SD, Altaf N The last two decades have seen a revolution in the treatment of Aortoiliac Occlusive Disease (AIOD). Acceptable safety and durability outcomes have now been realized with endovascular treatments, which is increasingly finding a place in the treatment of AIOD. Evolution of stent technologies and endovascular techniques is seeing an expansion of AIOD lesions indicated for primary endovascular treatment. The literature evidence basis is continuously evolving, and questions remain as to the optimal form of vessel treatment. Covered stents have been increasingly promoted for their long-term durability, particularly in extensive, challenging AIOD lesions. Here, we explore the seminal evidence basis for covered stents in the tr...
      PubDate: Wed, 30 Mar 2016 22:00:00 +010
       
  • Computed tomography assessment for transcatheter mitral valve
           interventions.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Narang A, Guerrero M, Feldman T, Pursnani A Multidetector cardiac computerized tomography (CT) is a robust advanced imaging modality with high spatial resolution that has emerged as an essential tool for the planning of structural heart and electrophysiology interventions. The most notable example has been its important role in the pre-procedural planning of transcatheter aortic valve replacement (TAVR), which has developed to the point that commercial software packages are commonly used for this application. More recently several novel approaches and devices have been developed for transcatheter mitral valve replacement (TMVR). Given the greater complexity of mitral valve anatomy, CT has at least an equally important role for pre-procedural planning of TMVR. Simi...
      PubDate: Tue, 29 Mar 2016 22:00:00 +010
       
  • Defining the clinical need and indications: who are the right patients for
           transcatheter mitral valve replacement'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Baumgarten H, Squiers JJ, Arsalan M, Dimaio JM, Mack MJ Mitral regurgitation (MR) can be divided into two major etiologies, primary and secondary MR. Primary MR, also termed degenerative or organic MR, is a disease of the valve itself and is treated routinely by surgical repair in all but prohibitive risk patients. In these patients, transcatheter repair techniques, including edge to edge repair with the MitraClip device have been largely successful and widely adopted. Transcatheter placement of artificial chords has also been performed. The potential role for transcatheter mitral valve replacement (TMVR) in primary MR will likely be quite limited. Secondary or functional MR is due to a disease of the left ventricle and not the valve itself. The MR is a result of ...
      PubDate: Tue, 29 Mar 2016 22:00:00 +010
       
  • Anatomical challenges for transcatheter mitral valve intervention.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : DE Backer O, Luk NH, SøNDERGAARD L Following the success of transcatheter aortic and pulmonary valve implantation, there is a large interest in transcatheter mitral valve interventions to treat severe mitral regurgitation (MR). With the exception for the MitraClipTM (Abbott, USA) edge-to-edge leaflet plication system, most of these transcatheter mitral valve interventions are still in their early clinical or pre-clinical development phase. Challenges arising from the complex anatomy of the mitral valve and the interplay of the mitral apparatus with the left ventricle (LV) have contributed to a more difficult development process and mixed clinical results with these novel technologies. This review aims to discuss the several anatomical aspects and challenges relat...
      PubDate: Tue, 29 Mar 2016 22:00:00 +010
       
  • Mitral regurgitation after previous aortic valve surgery for bicuspid
           aortic valve insufficiency.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: The risk of new-onset MR is significantly increased in patients with BAV regurgitation and aortic root dilatation who undergo isolated AVR rather than root replacement. The mechanism by which aortic root replacement may prevent the occurrence of late MR in BAV root phenotype patients is to be determined. PMID: 27012929 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 23 Mar 2016 23:00:00 +010
       
  • The CERAB technique: tips, tricks and results.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: The CERAB and C-CERAB techniques may change the treatment algorithm of extensive aortoiliac occlusive disease in the near future and appears to be a safe and feasible alternative with promising results, together with a more anatomical and physiological reconstruction of the aortic bifurcation, being a valid alternative for surgery and/orkissing stents. Critical issues that still needs to be solved, include cost-effectiveness, patient selection, fine-tuning of the technique and defining the optimal medical support. PMID: 27012930 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 23 Mar 2016 23:00:00 +010
       
  • Which surgical risk score is best for predicting outcome in patients
           undergoing trans-catheter aortic valve implantation: comparison of
           additive EuroScore, logistic EuroScore, EuroScore II, and the society of
           thoracic surgery global scoring systems.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: Surgical risk scores are poor at predicting outcomes in patients undergoing TAVI, particularly in the short term. PMID: 26981704 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 16 Mar 2016 00:00:00 +010
       
  • Single-centre experience with the Gore C3 Excluder stent-graft in 200
           consecutive patients.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: In this patient cohort, the C3 Excluder stent-graft provided excellent early and mid-term outcomes with null 30-day mortality in elective cases, and null type I endoleak and limb occlusion during follow-up. The option for repositioning was frequently utilized. Excessive repositioning resulted in three adverse events, all three successfully treated by endovascular means. PMID: 26981705 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 16 Mar 2016 00:00:00 +010
       
  • The spectrum of transcatheter mitral valve replacement devices.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Dudiy Y, Brownlee A, Ruiz CE Mitral regurgitation is the most common valvular heart disease. The gold standard for patients not suitable for valve repair is a surgical valve replacement. A significant proportion of patients, however are not referred for surgery due to comorbidities, advanced age or severe LV dysfunction. Transcatheter mitral valve replacement may be a viable therapeutic option for these high risk patients. With improvements in technology and data on the durability of the transcatheter mitral valve, this technology has the potential to be used in a lower risk population. A number of transcatheter systems have emerged recently and are at different stages of investigation. In this review, we outline the key elements and challenges of the transcathete...
      PubDate: Wed, 09 Mar 2016 00:00:00 +010
       
  • Techniques for aortic arch endovascular repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: This article reviews endovascular strategies for aortic arch repair. Open repair remains the gold standard particularly for good risk patients. Endovascular treatment potentially offers a less invasive repair. Principles, technical considerations, devices and outcomes of each technique are discussed and summarized. Hybrid repair combines less invasive revascularization options, instead of arch replacement while extending stent graft into the arch. Outcomes vary with regard to extent of repair and aortic arch pathologies treated. Results of arch chimney and other parallel graft techniques perhaps make it a less preferable choice for elective cases. However, they are very appealing options for urgent or bailout situations. Fenestrated stent grafting is subjected to many technical challenges ...
      PubDate: Fri, 04 Mar 2016 00:00:00 +010
       
  • "Obesity paradox" in transcatheter aortic valve implantation.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: BMI as continuous data may be associated with better early and mid-term post-TAVI survival. Whereas, overweight or obesity as categorized BMI may be associated with early, not mid-term, post-TAVI survival. PMID: 26939045 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 03 Mar 2016 00:00:00 +010
       
  • Current management of aortic arch lesions with hybrid procedures: a
           tailored approach to a progressive disease.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: The objective of this article is to review the current options for hybrid arch repair and the indications for choosing the various techniques based on pathologic presentation. PMID: 26939046 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 03 Mar 2016 00:00:00 +010
       
  • Mitral valve-in-valve and valve-in-ring for failing surgical bioprosthetic
           valves and rings.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Ghosh-Dastidar M, Narayana A, Boix R, Bapat V The transcatheter valve-in-valve (VIV) procedure for failed aortic bioprostheses is recognised as an alternative treatment to conventional surgery in high-risk patients. This less invasive option has now been applied to failed mitral bioprostheses (VIV) or failed repairs i.e. valve-in-ring (VIR). In this emerging field, to get an optimal result, a good understanding of the design features of the failed surgical heart valve/ring, the transcatheter heart valve being used and their compatibility, is of paramount importance. Although similar in many ways to the aortic counterpart, a mitral VIV/VIR procedure can pose certain different challenges such as delayed migration and left ventricular outflow tract obstruction. This ...
      PubDate: Mon, 29 Feb 2016 00:00:00 +010
       
  • Carotid artery stenting versus carotid endarterectomy. Updated
           meta-analysis, metaregression and trial sequential analysis of short-term
           and intermediate to long-term outcomes of randomized trials.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSIONS: In this largest and most comprehensive meta-analysis to date using outcomes that are standard in contemporary studies, CAS was associated with an increased risk of both periprocedural and intermediate to long-term outcomes. PMID: 26883249 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Wed, 17 Feb 2016 00:00:00 +010
       
  • The explosion of percutaneous mitral valve therapies.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Feldman T PMID: 26883145 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Tue, 16 Feb 2016 00:00:00 +010
       
  • Endovascular treatment of complex abdominal and thoracoabdominal type IV
           aortic aneurysms with fenestrated technology.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Fenestrated EVAR (fEVAR) has been shown to be safe and effective in the short and mid-term follow-up. Remaining issues including secondary interventions and the need for follow-up are still within the range of those reported for EVAR. These, continue to plague fEVAR for complex abdominal or type IV thoracoabdominal aortic aneurysms. PMID: 26845537 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Thu, 04 Feb 2016 00:00:00 +010
       
  • Vein harvesting and techniques for infrainguinal bypass.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : ALBäCK A, Saarinen E, Venermo M To achieve good long term results after bypass surgery, in addition to good inflow and outflow arteries, the bypass graft material has an important role. The best patency and limb salvage rates are achieved with autologous vein. If great saphenous vein is not available, acceptable long term results can be achieved with arm veins and lesser saphenous vein. The quality and size of the vein are important. A small-caliber vein, increased wall thickness, postphlebitic changes and varicosities are associated with a risk of early failure. Preoperative vein mapping with ultrasound reduces readmissions and postoperative surgical site infections. During the mapping, the vein to be used and its main tributaries are marked with a permanent mar...
      PubDate: Tue, 02 Feb 2016 00:00:00 +010
       
  • Precision medical and surgical management for thoracic aortic aneurysms
           and acute aortic dissections based on the causative mutant gene.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Milewicz DM, Hostetler E, Wallace S, Mellor-Crummey L, Gong L, Pannu H, Guo DC, Regalado E Almost one-quarter of patients presenting with thoracic aortic aneurysms or acute aortic dissections have an underlying mutation in a specific gene. A subset of these patients will have systemic syndromic features, for example, skeletal features in patients with Marfan syndrome. It is important to note that the majority of patients with thoracic aortic disease will not have these syndromic features but many will have a family history of the disease. The genes predisposing to these thoracic aortic diseases are inherited in an autosomal dominant manner, and thirteen genes have been identified to date. As the clinical phenotype associated with each specific gene is defined, the...
      PubDate: Tue, 02 Feb 2016 00:00:00 +010
       
  • New developments with drug-coated balloons.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Tepe G PMID: 26771719 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • How does a drug-coated balloon work' Overview of coating techniques
           and their impact.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Paclitaxel continues to be the drug of choice, the dose varies between 2 and 3.5 µg/mm² balloon surface. Neither animal experiments nor clinical trials have demonstrated problems in vessel segments treated with overlapping balloons. Future developments are expected to improve efficacy in additional disease conditions (e.g., calcified vessels) and vessel territories. PMID: 26771720 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Drug-coated balloons: what is the evidence'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Marques L, Hopf-Jensen S, Müller-Hülsbeck S Having evolved at a rapid pace, the therapy options for percutaneous treatment of peripheral arterial disease in the lower limbs, especially percutaneous transluminal angioplasty in combination with stent-technology, are able to deliver a rate where at least 80% of the treated patients remain free from reintervention after the first years under ideal study conditions, meaning that defined and often restrict in- and exclusion criteria were fulfilled and mid-term dual platelet therapy is warranted. This is somewhat a huge leap when compared to the 50-60% in the 1980s and 1990s, but we now face an era of an increasingly demanding clientele, where the industry also strives to cover this final 20% with newer technologies. A...
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Drug coated balloons below-the-knee: just too early'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Fanelli F, Cannavale A Patients with infrapopliteal arterial disease are generally considered challenging due to the usual presence of multivessel atherosclerotic disease. Several treatment options have been used by different authors but none of them can be considered ideal. In the last few years drug coated balloons have gained popularity especially due to the extraordinary results in the femoro-popliteal region. Following the great success, physicians started to use this promising device also in the below-the-knee (BTK) region. The initial enthusiasm correlated to some studies is not confirmed by the largest randomized trial, IN.PACT Deep, comparing In.Pact DCB to standard PTA. This trial failed completely to show the superiority of drug coated balloon (DCB). Th...
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • What are the potential limitations of drug coated balloons and possible
           ways to overcome.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Werk M In several independent randomized clinical studies, it has been shown that drug-coated balloons (DCBs) cause persistent clinically meaningful and statistically significant inhibition of restenosis in femoropopliteal arteries in comparison to percutaneous transluminal angioplasty with uncoated balloon catheters. The potential benefits of delivering an antiproliferative drug into the vessel wall using a balloon as transporter are manifold: 1) widespread applicability: balloon angioplasty is suitable for use in a wide range of lesions. The use of DCBs is technically less demanding and offers greater flexibility compared with stenting techniques. 2) Maintaining options: minimizing the use of durable implants is providing more options for following and complemen...
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Carotid interventions (CEA and CAS) in acute stroke patients: which
           procedure on which patient.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Darling RC, Warner C, Yeh CC, Shah MD, Hnath JC, Shah DM Treatment of carotid bifurcation disease in patients presenting with acute stroke has been a controversial issue over the past four decades. Classically, patients were asked to wait four to six weeks before intervention was entertained in order for the brain to stabilize and the risks of intervention to be minimized. Unfortunately, up to 20% of patients will have a secondary event after their index event and the window of opportunity to save potentially salvageable ischemic tissue will be missed. Early reports had demonstrated poor results with intervention. However, more recently, institutions such as ours have demonstrated excellent results with early intervention in patients who present with stable mild t...
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Endovascular intracranial treatment of acute ischemic strokes.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Rangel-Castilla L, Snyder KV, Siddiqui AH, Levy EI, Hopkins NL Acute ischemic stroke (AIS) is the leading cause of long-term disability and the second cause of death worldwide. Intravenous (IV) tissue plasminogen activator (tPA) remains the only FDA-approved treatment for AIS. The use of IV tPA in AIS related to large-vessel occlusion (LVO) has shown low recanalization rates and poor clinical outcomes. Over the last decade, endovascular treatment has demonstrated safety and effectiveness in the management of LVO-associated AIS due to the evolution of endovascular techniques and technologies, beginning with intraarterial thrombolysis, aspiration, self-expanding intracranial stents, and now retrievable stents. With the recent publication of the results of five rando...
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Acute stroke: balloon-tipped catheter in thrombectomy.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Mathias K The management of acute stroke has changed in the recent past due to the superior results of thrombectomy in patients with occlusion of larger brain supplying arteries in comparison to intravenous thrombolysis. This progress is mainly based on the use of stent retrievers for thrombectomy. The combination of stent retrievers with balloon-tipped catheters has increased the efficacy of the procedure. PMID: 26771726 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Transcranial Doppler and diffusion-weighted magnetic resonance evaluation
           of cerebral embolization occurring during transfemoral carotid stenting
           with proximal flow blockage.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: While achieving good technical and clinical results, CAS with proximal flow blockage is still accompanied by a non-negligible cerebral embolization. The detection of MES during ICA flow blockage suggests the need for a better selection of patients. PMID: 26771727 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • Outcome of extensive descending aorta repair adopting present concepts of
           spinal cord preservation.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Even without the Adamkiewicz artery identification and neuromonitoring, the incidence of immediate paraplegia could be kept low by applying the strategy based on the modern concept of cord perfusion. The relatively high incidence of delayed deficit suggests the importance of postoperative hemodynamic management and prevention of cardiopulmonary complications. PMID: 26771728 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:09 +010
       
  • How to calculate the main aortic graft-diameter for a chimney-graft.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Geometric approximation can be used to calculate the required main aortic graft-diameter. For parallel running chimney-grafts a significant degree of oversizing is necessary to allow the main aortic body to surround the chimney and to prevent the occurrence of gutters, which may cause type-1 endoleaks. PMID: 26771729 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:08 +010
       
  • Abdominal aortic aneurysm.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Setacci F, Galzerano G, DE Donato G, Benevento D, Guerrieri MW, Ruzzi U, Borrelli MP, Setacci C Endovascular repair of abdominal aortic aneurysms has become a milestone in the treatment of patients with abdominal aortic aneurysm. Technological improvement allows treatment in more and more complex cases. This review summarizes all grafts available on the market. A complete review of most important trial on this topic is provided to the best of our knowledge, and technical tips and tricks for standard cases are also included. PMID: 26771730 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:08 +010
       
  • Endovascular treatment of an early arch aneurysm rupture after open
           thoracoabdominal aortic repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: We present the case of a patient with a ruptured aortic arch aneurysm after open-surgery for a type III thoracoabdominal aortic aneurysm. Our therapeutic decision is described and discussed, with all the related advantages and disadvantages. PMID: 26771731 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:07 +010
       
  • Is low anticoagulation intensity more beneficial for patients with
           bileaflet mechanical mitral valves' A meta-analysis.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Compared with the recommended high intensity, low anticoagulation intensity (median INR<2.5) may be more beneficial for the MVR patients using the lowest thrombogenic risk bileaflet valves. We recommended an INR between 2.0 and 2.5, with a median INR of 2.3 for these MVR patients. PMID: 26771732 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:07 +010
       
  • Eptifibatide infusion versus placebo in high risk patients with non-ST
           segment elevation acute coronary syndromes managed with urgent coronary
           artery bypass graft surgery. A prospective multicenter randomized
           placebo-controlled clinical trial.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Preoperative use of eptifibatide vs. placebo is linked to significantly reduced 12-month MACCE rate in patients with NSTE-ACS requiring urgent CABG, while it simultaneously seems not to confer a greater risk of postoperative bleeding. PMID: 26771733 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:07 +010
       
  • Right miniparasternotomy may be a good minimally invasive alternative to
           full sternotomy for cardiac valve operations: a propensity-adjusted
           analysis.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: The propensity-adjusted analysis demonstrated encouraging safety and quality outcomes for mini-parasternotomy valve operation in carefully selected patients. PMID: 26771734 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:07 +010
       
  • Mitral valve replacement in the elderly is associated with low mortality
           and similar survival to the general population.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract: CONCLUSION: Mitral valve replacement is a feasible option for elderly patients with mitral valve disease in centers with lack expertise in valve repair. Actual surgical results provide low operative mortality and similar survival to general the population (mainly in females). PMID: 26771735 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Sat, 16 Jan 2016 14:50:07 +010
       
  • Is a history of radiation therapy a contra-indication for carotid
           surgery'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Vos JA, VAN Leersum M, DE Vries JP Advances in surgical and medical oncology have seen a significant increase in survival of patients suffering from head and neck malignancies. Many of these patients are treated with radiotherapy to the neck, including the cervical carotid artery. Cervical irradiation (CI) may induce carotid stenosis. Prior CI in association with carotid artery stenosis poses potential challenges, when revascularization is considered. As the focus of radiotherapy determines the level of the resultant obstruction it may be in a location that is difficult to reach surgically. Also scar tissue from CI may increase the risk of cranial nerve injury. Carotid angioplasty and stenting (CAS) may be an alternative for CEA in post CI cases. This manuscript a...
      PubDate: Fri, 15 Jan 2016 00:00:00 +010
       
  • Management of in-stent restenosis in the superficial femoral artery.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : VAN DEN Berg JC This manuscript will provide a description of the process of (in-stent) restenosis and the histopathological changes involved. Furthermore it will give an overview of the current status of the literature of the various therapeutic options that are available for the treatment of in-stent restenosis. PMID: 26771868 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Fri, 15 Jan 2016 00:00:00 +010
       
  • Treatment options for post-dissection aortic aneurysms.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Sobocinski J, Patterson BO, Clough R, Spear R, Martin Gonzalez T, Azzaoui R, Hertault A, Haulon S Aortic dissection is one of the most devastating catastrophes that can affect the aorta. Surgical treatment is proposed only when complications such as rupture or malperfusion occur. No clear consensus has been reached regarding the best therapy to prevent aortic rupture after the acute phase. We have performed a thorough review of the most recent literature on the strategies to treat patients in the chronic phase of aortic dissection. PMID: 26771869 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Fri, 15 Jan 2016 00:00:00 +010
       
  • Vessel involvement in giant cell arteritis: an imaging approach.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Holm PW, Sandovici M, Slart R, Glaudemans AW, Rutgers A, Brouwer E Vasculitis is classified based on the size of the involved vessels. The two major forms are small vessel vasculitis (SVV) and large vessel vasculitis (LVV). Main forms of LVV are Takayasu Arteritis (TA), Giant Cell Arteritis (GCA), Isolated Aortitis (IA) and Chronic Periaortitis (PC). This manuscript will focus on giant cell arteritis (GCA), named after the presence of giant cells in the artery vessel wall. A positive biopsy of the temporal artery is the gold standard for making a diagnosis of GCA. In the past 10 years the introduction of new imaging techniques in GCA patients has revealed a variable prevalence of extra cranial involvement, challenging the temporal artery biopsy as gold standard. A...
      PubDate: Tue, 12 Jan 2016 00:00:00 +010
       
  • Diagnostic algorithms and treatment strategies in primary aortic and
           aortic graft infections.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Schurink GW, Peppelenbosch N, Mees B, Jacobs MJ Aortic infections and aortic graft infections are one of the most dreadful clinical entities that a vascular surgeon can face. Clinical presentation of the patient can vary greatly and diagnosis can be difficult to make. In this manuscript, diagnostic modalities are reviewed and a diagnostic algorithm suggested. Further, results of present treatment options are evaluated and treatment strategies for different clinical scenarios suggested. PMID: 26745263 [PubMed - as supplied by publisher] (Source: The Journal of Cardiovascular Surgery)
      PubDate: Fri, 08 Jan 2016 00:00:00 +010
       
  • Towards individualized follow-up protocols after endovascular aortic
           aneurysm repair.
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Laturnus J, Oliveira N, Gonçalves FM, Schurink GW, Verhagen H, Jacobs MJ, Mees B Endovascular aneurysm repair (EVAR) has become the primary treatment option for elective abdominal aortic aneurysms. However, a significant number of patients require secondary interventions to maintain adequate aneurysm exclusion and ultimately prevent death from AAA rupture. To maintain success and offer timely secondary intervention, intensive image surveillance has been recommended. These rigorous surveillance regimens are costly and may have deleterious effects from radiation and contrast exposure. Improvements in patient selection, operative technique and devices have caused a decline in complications after EVAR. Therefore, there is a need to reduce surveillance after EVAR for ...
      PubDate: Fri, 08 Jan 2016 00:00:00 +010
       
  • Spinal cord ischemia is multifactorial: what is the best protocol'
    • Authors: The Journal of Cardiovascular Surgery
      Abstract:
      Authors : Melissano G, Bertoglio L, Mascia D, Rinaldi E, Del Carro U, Nardelli P, Chiesa R Despite the improved understanding of spinal cord anatomy and spinal cord ischemia pathophysiology, the rate of debilitating postoperative paraparesis or paraplegia is still not negligible after procedures for thoracic or thoracoabdominal aortic disease. Single studies have demonstrated the role of different treatment modalities to prevent or treat spinal cord ischemia. A multimodal approach, however, is advocated by most authors. Even after the employment of endovascular techniques become routine, the rate of spinal cord ischemia after treatment of thoracoabdominal aortic pathology remained unchanged over time. Spinal cord ischemia is often treatable by different means that concur to...
      PubDate: Tue, 05 Jan 2016 00:00:00 +010
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.163.166.22
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016